Evaluation of Treatment Efficacy of a Modified Positive Airway Pressure Device to Treat Obstructive Sleep Apnea

This study will investigate the efficacy of the FPH modified positive airway pressure (PAP) device with or without SensAwake; and with different pressure support in OSA participants; in both an in-home and in-lab environment. Comfort, compliance and the accuracy of the pressure delivery will also be evaluated. The FPH device will be compared to a market released product.

Inclusion Criteria:

• Aged 18 and over
• Diagnosed with OSA by a practicing physician and prescribed Positive Airway Pressure (PAP) - (Continuous Positive Airway Pressure (CPAP) or AutoCPAP). Participants can be naïve to CPAP or experienced users of CPAP.
• For experienced users of PAP (CPAP or AutoCPAP): Using the PAP of more than 4 hours/night for 70% during the last 30 days (justification allowed by the investigator)

Exclusion Criteria:

• Contraindicated for PAP (CPAP or AutoCPAP) therapy
• Persons with other significant sleep disorder(s) (e.g periodic leg movements, insomnia, central sleep apnea)
• Persons with obesity hypoventilation syndrome or congestive heart failure.
• Persons that require supplemental oxygen with their PAP (CPAP or AutoCPAP) device
• Persons with implanted electronic medical device (e.g cardiac pacemakers)
• Persons who are pregnant or think they might be pregnant.